- Image via Wikipedia
The transformation of a tough 13-page conflict of interest policy into a streamlined two-page version at the University of Minnesota Medical School show how hard it can be to separate industry from academia, according to the Minneapolis Star-Tribune.
The initial draft included a provision that required clinical trials subjects to be enrolled by patient advocates as opposed to doctors involved in the study. A particularly controversial change involved a portion that eliminated industry funding for continuing medical education classes.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Originally, the policy would have ended industry support within five years. The new version permits the funding under the rules of a national accrediting organization, according to the newspaper.
“We have no alternative source of funding for it,” Medical School Dean Dr. Deborah Powell told the paper. “As the economy worsens, a lot of the people who take our courses can’t afford to pay the tuition. Our courses are attended by nurses, pharmacists, physicians, and people felt we couldn’t raise the tuition.
“I wish a lot of the controversy had not happened, because I think this process was really important for the school, its faculty and the students,” she said. “But I think we’ve arrived at a good place.”
Other stories worth a read:
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
- U.S. scientists follow yellow brick roads overseas (Lens)
- Wichita State receives $250K commitment for dentistry program (Wichita Business Journal)
- The American Medical Student Association gets an F in science based medicine (Notes from Dr. R W)
- White House Health Care Summit a ‘dog and pony show’ (Doctor Anonymous)
